Back to search
Autosomal Dominant Hypocalcemia (ADH)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Autosomal Dominant Hypocalcemia (ADH) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Autosomal Dominant Hypocalcemia (ADH) trials you may qualify forThe primary purpose of the study is to understand the effectiveness, safety, and tolerability of encaleret when compared to standard of care (SoC) treatment in…
The primary purpose of this study is to evaluate the safety, tolerability and effectiveness of encaleret in participants with Autosomal Dominant Hypocalcemia Ty…
This is an open-label study looking at the effects of NPSP795 (a selective calcium receptor antagonist) on activating mutations of the Calcium-sensing receptor…